Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-056427

President and CEO sold 42,000 shares at an average $20.06 ($842,520)

  • President and CEO acquired 42,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanjiv President and CEO 2022-11-08 Option exercise +14,000 $4.12 $57,680 268,554 D
Patel Sanjiv President and CEO 2022-11-08 Sale −14,000 $20.18 $282,520 254,554 D
Patel Sanjiv President and CEO 2022-11-10 Option exercise +18,175 $4.12 $74,881 272,729 D
Patel Sanjiv President and CEO 2022-11-10 Sale −18,175 $20.00 $363,500 254,554 D
Patel Sanjiv President and CEO 2022-11-10 Option exercise +9,825 $5.04 $49,518 264,379 D
Patel Sanjiv President and CEO 2022-11-10 Sale −9,825 $20.00 $196,500 254,554 D
Derivatives
Patel Sanjiv President and CEO 2022-11-08 Option exercise · Stock Option (Right to Buy) −14,000 18,175 D
Patel Sanjiv President and CEO 2022-11-10 Option exercise · Stock Option (Right to Buy) −18,175 0 D
Patel Sanjiv President and CEO 2022-11-10 Option exercise · Stock Option (Right to Buy) −9,825 694,779 D
Open-market sales · 42,000 sh · avg $20.06 · $842,520
Loading xslF345X03/doc4.xml…